Draxis Health, Inc. has made senior level organization changes in an effort to streamline its core operating businesses in Montreal. Effective immediately, Mr. Jean-Pierre Robert assumes the role of president of Draxis Specialty Pharmaceuticals, Inc. (DSP), which provides sterile products, non-sterile products and radiopharmaceutical products.

Mr. Robert was previously president of Draximage, the division of DSP that produces and markets radiopharmaceutical products. Mr. Robert will also have responsibility for Draxis Pharma, the contract manufacturing division of DSP.

Also, the office of the president has been established at the corporate level and will include Dr. Martin Barkin, president and chief executive officer of Draxis Health Inc., and Dan Brazier, chief operating officer. Dr. Barkin and Mr. Brazier will retain their current responsibilities. Mr. Robert will report to Mr. Brazier.

“This revised organizational structure reflects our desire to further streamline our Montreal operations while recognizing that future growth will come from three specialized functional areas,” said Dr. Barkin. “The appointment of Jean-Pierre to this new position means that we will continue to benefit from efficiencies that we have already seen through the integration of a number of functions such as finance, information technology, logistics and human resources.”

Prior to joining Draxis in April 2005, Mr. Robert spent several years with Tyco Healthcare (Canada), most recently as vice president and general manager, where he oversaw domestic and export operations, including marketing, sales, finance and contract manufacturing operations. Most recently, he was president and chief executive officer of an emerging Canadian biotechnology company. Mr. Robert has 27 years experience in the pharmaceutical industry.